Using chemotherapy to delay or avoid radiotherapy in children under three with a type of brain tumour called ependymoma reduces the risk of potentially damaging long term side effects, reveal trial results published online in the Lancet Oncology.
Neuroscientists are attempting to understand if structural changes in the brain are related to sensory experience or the performance of learned behavior, and now University of Washington researchers have found evidence that one species of songbird apparently has something in common with a few baseball sluggers.
A recent study at Hamilton Health Sciences proves that sperm freezing and banking is an effective way to preserve fertility in adolescents and young adult (AYA) males with cancer.
Results from a new study involving high blood pressure patients taking Tekturna? (aliskiren) and Diovan? (valsartan) were published in The Lancet.
A study in Nature Neuroscience online proposes a role for sugar as the hinge that opens a gate in the cell membrane and brings news of nicotine?s arrival. Finding could lead to improved treatments for substance addiction, depression, epilepsy and other disorders.
Combining research and practice, the University of Kentucky is taking steps to eradicate violence against women by focusing on peer influence and intervention.
The commonly used and inexpensive analgesic acetaminophen (Tylenol or paracetamol) is an effective pain reliever after surgical removal of lower wisdom teeth, according to a new systematic review of 21 studies. The most effective dose appears to be 1,000 milligrams taken at six-hour intervals, the review concludes.
An international collaboration between European, Australian and American researchers has unveiled some of the genetic mysteries explaining why some people naturally keep HIV levels almost undetectable, whereas others quickly lose control of the infection.
What people have come to expect in cell phones and personal communicators may soon become common in health-care devices and products at home and in medical offices, thanks to new technology announced today by the University of Florida and IBM.
The Paul Milstein family has donated $5.5 million to create the Milstein Medical Research Program at Rockefeller University. The initial research efforts will be in the area of skin cancer and will be led by Dr. James G. Krueger, D. Martin Carter Professor and head of the Laboratory for Investigative Dermatology at Rockefeller.